Dr. John Patrick Carmody, MD

Dr. Carmody practices at Huntington Hospital - Unit in Pasadena, California.

Dr. Carmody's NPI, 1598732448, was assigned on February 28, 2006. Dr. Carmody graduated from West Virginia University School Of Medicine in 1989. Dr. Carmody's California license number on file is G74034.

Dr. Carmody's primary practice is Huntington Hospital - Unit, at 100 W. California Blvd, Pasadena, CA 91105 in Los Angeles County. The practice phone is (626) 397-2618.

Dr. Carmody's primary practice is Huntington Hospital - Unit in Pasadena, California. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Carmody to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carmody practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Carmody's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Carmody is board certified in pulmonary disease by the American Board of Internal Medicine. Dmand AI has Dr. Carmody's licenses on file in 2 states: California and Michigan.

Dmand AI lists anemia, cardiac arrhythmia, cellulitis, chronic diabetes, chronic hypertension, chronic kidney disease, cirrhosis and congestive heart failure among the conditions Dr. Carmody treats.

CMS data shows 355 Medicare services from Dr. Carmody across 5 procedure codes in 2024, for 124 Medicare patients. Medicare paid $24,651 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 124 Medicare patients who saw Dr. Carmody in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 67% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carmody's median patient age at 73, with 51% women.

In 2024, Dr. Carmody wrote 28 Medicare Part D claims. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $6,996 in total drug cost. In 2021, CMS named 26 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Carmody for performance year 2024, reported as part of a group.

Dmand AI links 14 papers to Dr. Carmody, published from 2011 to 2022. 2014 was the busiest year, with 4. The most frequent topics are Dementia, Automobile Driving and Australia. Dr. Carmody has published most often in Aust Fam Physician. Dr. Carmody's most frequent co-authors are William A. Byrd, MD, Lauren C. Ditta, MD and Bryan Johannes Vekovius, MD.

CMS Open Payments shows 6 general payments to Dr. Carmody from 5 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $63.

Dmand AI lists 2 awards for Dr. Carmody, most recently CMS Stage 1 EHR in 2013.

Dr. Carmody graduated from West Virginia University School Of Medicine in 1989.

Dr. Carmody is in network with 13 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.